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Objective: This cross-sectional study was set in an academic medical center and conducted to identify associations of
physical activity level and walking exercise frequency with calf skeletal muscle characteristics in individuals with lower
extremity peripheral arterial disease (PAD).
Methods: Calf muscle characteristics in 439 men and women with PAD were measured with computed tomography at
66.67% of the distance between the distal and proximal tibia. Physical activity was measured continuously during 7 days
with a vertical accelerometer. Patient report was used to determine the number of blocks walked during the past week and
walking exercise frequency. Results were adjusted for age, sex, race, comorbidities, ankle-brachial index, bodymass index,
smoking, and other confounders.
Results: For both objective and subjective measures, more physically active PAD participants had higher calf muscle area
and muscle density. Calf muscle area across tertiles of accelerometer-measured physical activity were first activity tertile,
5071 mm2; second activity tertile: 5612 mm2; and third activity tertile, 5869 mm2 (P< .001). Calf muscle density across
tertiles of patient-reported blocks walked during the past week were first activity tertile, 31.4 mg/cm3; second activity
tertile, 33.0 mg/cm3; and third activity tertile, 33.8 mg/cm3 (P< .001). No significant associations were found between
walking exercise frequency and calf muscle characteristics.
Conclusion: Among participants with PAD, higher physical activity levels, measured by accelerometer and by patient-
reported blocks walked per week, were associated with more favorable calf muscle characteristics. In contrast, more
frequent patient-reported walking exercise was not associated with more or less favorable calf muscle characteristics.
Results suggest that clinicians should encourage their patients to increase their walking activity during daily life. ( J Vasc
Surg 2007;46:87-93.)Individuals with lower extremity peripheral arterial dis-
ease (PAD) have reduced calf skeletal muscle area com-
pared with those without PAD.1-4 This finding is not
entirely explained by differences in physical activity levels
between people with and those without PAD. Available
data suggest that leg ischemia may have a direct, negative
effect on calf skeletal muscle area, independent of physical
activity levels.1,4 For example, among individuals with PAD
who have significant differences in the ankle-brachial index
(ABI) between the right and left legs, the leg with the lower
ABI has significantly lower calf muscle area than the leg
with the higher ABI.1,4
Previous study demonstrates that among patients with
PAD, larger calf muscle area is associated with greater
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doi:10.1016/j.jvs.2007.02.064distance achieved during the 6-minute walk test and faster
walking speed over 4 meters.4 Identifying clinical charac-
teristics associated with larger calf muscle area and other
more favorable calf muscle characteristics may ultimately
help identify effective therapies for improving functioning
in individuals with PAD.
Clinical characteristics that are associated with more
favorable calf muscle characteristics in individuals with
PAD are unknown. For example, although patient-
reported walking exercise is associated with slower rates of
functional decline in patients with PAD, associations of
patient-reported walking exercise with calf muscle area in
patients with PAD are unknown.5 It is similarly unclear
whether higher levels of physical activity are associated with
more favorable calf muscle characteristics among individu-
als with PAD. Individuals with PAD have significantly
lower physical activity levels than those without PAD,6,7
and it is unknown whether differences in calf muscle char-
acteristics are observed across the range of physical activity
levels typically observed in patients with PAD.
Walking activity during daily life is a distinct measure
from walking exercise activity, in part because walking
activity may be less intensive than walking exercise activity.
People may also be very physically active during daily life
without engaging in walking exercise. Therefore, the pur-
pose of this study was to assess associations of greater
87
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reported walking exercise with calf muscle area and calf
muscle density in people with PAD.
METHODS
Participants. The protocol was approved by the In-
stitutional Review Board of Northwestern University
Feinberg School of Medicine and Catholic Health Part-
ners Hospitals. Participants gave informed consent. Par-
ticipants included individuals attending their fourth an-
nual follow-up visit in the Walking and Leg Circulation
Study (WALCS)8,9 and individuals newly identified for
the present study (WALCS II).10 Participants were aged
59 years. For both WALCS and WALCS II, PAD
participants were identified consecutively from among
patients diagnosed with PAD in three Chicago-area non-
invasive vascular laboratories. The rest were identified
from among consecutive patients in a general medicine
practice at Northwestern. PAD was defined as an ABI
 0.90.8-10
Exclusion criteria have been described and include
dementia, nursing home residence, inability to walk with-
out a wheelchair, foot or leg amputation, and recent lower
extremity revascularization.10 These exclusion criteria were
applied at the time of study entry for WALCS orWALCS II
and were selected because they interfered with the partici-
pant’s ability to respond accurately to study questionnaires
or they severely impaired lower extremity functional per-
formance. Because study staff members were not fluent in
non-English languages, potential participants who did not
speak English were excluded.
Ankle-brachial index. After participants rested supine
for 5 minutes, a hand-held Doppler probe (Nicolet Vascu-
lar Pocket Dop II, Golden, Colo) was used to measure
systolic pressures in the right brachial, dorsalis pedis, and
posterior tibial arteries and left dorsalis pedis, posterior
tibial, and brachial arteries. Pressures were measured in the
order listed and then in reverse order. The ABI was calcu-
lated by dividing average pressures in each leg by the
average of the four brachial pressures.11,12 This method of
ABI calculation was used because it has previously been
shown to be more closely correlated with lower extremity
performance than alternative methods.11 However, analy-
ses were also performed in which the ABI was calculated
using the highest pressure in each leg. Average brachial
pressures in the arm with highest pressure were used when
one brachial pressure was higher than the opposite brachial
pressure in both measurement sets and the two brachial
pressures differed by 10 mm Hg in at least one measure-
ment set.13 The lowest leg ABI was used in analyses.
Measuring calf muscle characteristics. A computed
tomography (CT) scanner (LightSpeed, General Electric
Medical Systems, Waukesha, Wis) was used to obtain a
2.5-mm cross-sectional image of the calves at 66.7% of the
distance from the distal to the proximal tibia.14 Cross-
sectional images were analyzed using BonAlyse (BonAlyse
Oy, Jyvaskyla- Finland), a software for processing CT im-
ages that identifies muscle tissue and uses validated meth-ods to measure density and geometry.14,15 The muscle
outline was traced manually, excluding subcutaneous fat,
intermuscular fat, and bone.
Digital CT images consist of pixels representing a
three-dimensional unit of space (a cube) measured in vox-
els. Voxels on the CT images range from –1000 (the
density of air) to2000 (the density of bone). Zero voxels
corresponds to the density of water. When measuring mus-
cle area, BonAlyse software quantifies voxels within a range
corresponding to muscle density (9 to 271 mg/cm3),
excluding voxels corresponding to fat (–270 to 8 mg/
cm3). These definitions for muscle density and fat density
were determined before data collection was initiated and
were based on prior study and consultation with a radiolo-
gist with expertise in CT scan measurements.14 CT scans
were performed in all participants. In 40 legs, the inter-
rater reliability of muscle area was 0.99, and inter-rater
reliability of muscle density was 0.99.
Six-minute walk test. Following a standardized pro-
tocol,8,9,16 participants walk up and down a 100-foot hall-
way for 6 minutes after instructions to cover as much
distance as possible. The 6-minute walk test was completed
by 416 (95%) of the 439 participants. Test retest reliability
of the 6-minute walk was 0.87 (P .001) in our laboratory
among 81 PAD participants who completed the test ap-
proximately 1 to 2 weeks apart.17
Four-meter walking velocity. Walking velocity was
measured over 4meters at usual pace. This measure assesses
usual walking speed over short distances. In contrast, the
6-minute walk specifically measures walking endurance. As
in previous studies that validated the 4-meter walking ve-
locity, the walk was performed twice and the faster walk was
used in analyses.8,9,18 The 4-meter walk test was completed
by 422 (96%) of the 439 participants. Test retest reliability
was 0.82 (P  .001) in our laboratory among 84 PAD
participants who completed the test approximately 1 to 2
weeks apart.17
Accelerometer-measured physical activity. Physical
activity levels were measured objectively and continuously
for 7 days by using a vertical accelerometer (Caltrac,Muscle
Dynamics Fitness Network Inc, Torrance, Calif).6,7,19 The
Caltrac accelerometer is worn at the hip and measures
vertical movement at the hip; thus, it primarily measures
walking activity. After 7 days, participants reported the
number of activity units displayed on the accelerometer by
telephone to investigators and returned their accelerometer
by mail. We programmed the accelerometer identically for
all participants, which allowed us to compare physical ac-
tivity levels between participants, irrespective of individual
variation in age, weight, height, and sex.6,7,19-21 Pro-
grammed in this way, the accelerometers measured “activ-
ity units.”6,7,19-21
The validity of the Caltrac accelerometer for measuring
physical activity in patients with PAD has been demon-
strated previously.6,7,19 For example, in one study, there
were no differences in accelerometer scores between sub-
jects with and without PAD for a fixed distance of 800 feet.
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lower Caltrac-assessed activity than non-PAD participants.7
Of participants with PAD who were eligible for this
study, 60% wore a Caltrac monitor for 7 days. Systematic
data on reasons that some participants did not wear moni-
tors were not collected. Some participants refused to wear
monitors, others wore monitors but did not return them
and could not be reached at 7-day follow-up, some moni-
tors malfunctioned, and in some instances, no monitors
were available.
Patient-reported physical activity and walking exer-
cise frequency. The number of blocks walked during the
previous 7 days was obtained from patient report.19 At the
initial visit, participants were asked, “During the last week,
how many city blocks or their equivalent did you walk? Let
12 city blocks equal one mile.” Previous study shows that
Caltrac accelerometer-measured activity is significantly as-
sociated with the number of blocks walked during the past
week.19 For walking exercise, participants who responded
affirmatively to the question, “During the past two weeks,
have you gone walking for exercise?” were classified as
current exercisers.5 Participants were asked to report the
number of times they went walking for exercise during the
prior week.5 A previous study that used these specific
questions showed that PAD participants who go walking
for exercise three or more times per week have less average
annual functional decline than PAD participants who walk
less frequently for exercise or not at all.5
Leg symptoms. The San Diego Claudication Ques-
tionnaire8,9,22 was used to classify leg symptoms into one of
five groups: (1) intermittent claudication, (2) leg pain on
exertion and rest, (3) atypical exertional leg pain/carry on,
(4) atypical exertional leg pain/stop, and (5) asymptom-
atic.
Comorbidities. Algorithms developed for the Women’s
Health and Aging Study were used to document comorbidi-
ties, in which data were combined from patient report, phys-
ical examination, medical record review, medications, labora-
tory values, and a primary care physician questionnaire.23
Comorbidities assessed were angina, diabetes mellitus, myo-
cardial infarction, stroke, heart failure, pulmonary disease,
cancer, spinal stenosis, and disk disease. American College of
Rheumatology criteria were used to adjudicate knee and hip
osteoarthritis.24,25
Other measures.Height and weight were measured at
the study visit. Body mass index (BMI) was calculated as
weight in kg/height in meters.2 Cigarette smoking history
was based on self-report.
Statistical analyses.Differences in calf muscle area and
calf muscle density were evaluated across tertiles of each
physical activity measure and across categories of walking
exercise by using analyses of covariance, adjusting for age,
race, sex, recruitment cohort (WALCS vs newly identified),
and tibia length (muscle area analyses only). Analyses were
repeated with additional adjustment for smoking, BMI, leg
symptoms, and comorbidities. Analyses of muscle area were
adjusted for tibia length because greater tibia length is
associated with greater calf muscle area. These analyseswere adjusted for both BMI and tibia length because BMI
is a measure of obesity, and tibia length measures height.26
Average performance on each functional measure was
compared across tertiles of vertical accelerometer-measured
physical activity by using analyses of covariance and adjust-
ing for age, race, gender, cigarette smoking, BMI, leg
symptoms, ABI, recruitment cohort, and comorbidities.
To determine whether significant associations were poten-
tially explained by associations between higher physical
activity levels andmore favorable calf muscle characteristics,
analyses were repeated with additional adjustment for calf
muscle area and tibia length and calf muscle density, respec-
tively. All analyses involving the Caltrac vertical accelerom-
eter were repeated using inverse weighting to adjust for
missing data. Analyses were performed using SAS 9.0 sta-
tistical software (SAS Inc, Cary, NC).
RESULTS
The 439 PADparticipants consisted of 214 consecutive
WALCS cohort members attending their fourth annual
follow-up visit and 225 who were newly identified. Partic-
ipation rates for theWALCS cohort have been described.8,9
Newly identified participants were recruited from among
1804 men and women contacted for potential participa-
tion. Of these, 176 (9.8%) met exclusion criteria, 131
(7.3%) refused participation, 1021 (57%) did not respond
to letters inviting their participation, 74 (4.1%) did not
show for their study appointment, and 162 had an ABI
0.90 and were excluded from analyses. An additional 15
(0.01%) attended a visit but did not undergo CT scanning.
The average age of PAD participants was 74.9  8.2
years, and 47% were women. In addition, 16.9% were
African American, 15.7% were current smokers, 31.7% had
diabetes mellitus, and 57.9% had a history of coronary or
cerebrovascular disease. The average ABI was 0.63 0.16.
Of the 439 PAD participants, 263 (59.9%) wore a Caltrac
accelerometer for 7 days. There were no differences be-
tween wearers vs nonwearers in age (74.7  8.3 years vs
75.4  8.2 years, P  .392), ABI (0.63  0.15 vs 0.63 
0.15, P  .77) or prevalence of men (52.1% vs 54.5%, P 
.61) or African Americans (16.7% vs 17.0%, P  .93).
Participants who wore accelerometers had better 6-minute
walk performance (1147 375 feet vs 1064 427 feet, P
 .039) compared with nonwearers. The 4-meter walking
speed between accelerometer wearers and nonwearers was
similar at 0.86 0.20 m/s vs 0.85 0.24 m/s (P .852).
Analyses adjusting only for age, sex, race, recruitment
cohort, and tibia length showed a nonstatistically signifi-
cant trend toward higher calf muscle density among partic-
ipants who engaged in more frequent walking exercise: no
walking exercise, 32.2 mg/cm3; walking exercise one or
two times per week, 32.6 mg/cm3; and walking exercise
more than three times per week, 33.0 mg/cm3 (P .095).
No significant associations were observed between patient-
reported walking exercise and calf muscle area, adjusting
for age sex, race, and recruitment cohort (data not shown).
No significant relationships were found between walking
exercise frequency with calf muscle outcomes, adjusting for
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bidities, leg symptoms, recruitment cohort, smoking, and
ABI (Fig 1, Fig 2).
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area only). Results were similar when analyses in Fig 1 and
Fig 2 for blocks walked during the prior 7 days and walking
exercise frequency were repeated within the subset of par-
ticipants whowore Caltrac vertical accelerometers (data not
shown).
Higher accelerometer-measured physical activity ter-
tiles were associated with better 6-minute walk perfor-
mance and faster 4-meter walking speed among PAD par-
ticipants, adjusting for age, sex, race, BMI, smoking,
recruitment cohort, leg symptoms, comorbidities, and ABI
(Table, model 1). To determine whether these associations
were potentially explained by more favorable calf muscle
characteristics among more physically active PAD partici-
pants, analyses were repeated with additional adjustment
for calf muscle area (Table, model 2) and calf muscle
density (Table, model 3). The association between higher
physical activity levels and better 6-minute walk perfor-
mance was not substantially changed after additional ad-
justment for each calf muscle characteristic.
This finding suggests that significant associations be-
tween higher physical activity levels and better 6-minute
walk performance are not likely to be attributable to the
more favorable skeletal muscle characteristics among more
physically active PAD participants. However, after addi-
tional adjustment for calf muscle characteristics, associa-
tions of higher physical activity levels and faster 4-meter
walking speed were less marked and of borderline statistical
significance (Table). These latter findings suggest that the
greater calf muscle area and greater calf muscle density
Table. Associations between physical activity levels and
functional performance levels in participants with
peripheral arterial disease*
Test
Activity units
P trendTertile 1 Tertile 2 Tertile 3
Six-minute walk test in
feet (n  260)†
Model 1 1043 1172 1275 .001
Model 2 1074 1165 1252 .001
Model 3 1083 1163 1245 .001
Four-meter walking
velocity (usual pace)
in m/s (n  261)†
Model 1 0.817 0.852 0.915 .001
Model 2 0.842 0.847 0.896 .037
Model 3 0.844 0.846 0.894 .056
*Results shown represent average performance on each measure of lower
extremity performance (dependent variable) according to tertiles of acceler-
ometer-measured physical activity levels (independent variable), adjusting
for confounders. The variables adjusted for in each model are: model 1 
adjusted for age, sex, race, body mass index, smoking, recruitment cohort,
leg symptoms, comorbidities, and ankle-brachial index; model 2 adjusted
for variables in model plus muscle area and tibia length; model 3 adjusted
for variables in model plus muscle density.
†N represents the number of participants with peripheral arterial disease in
each analysis. N values are smaller than data in Fig 1 and Fig 2 because
accelerometer data were available for 60% of PAD participants.observed in more physically active PAD participants may beresponsible for the associations of higher physical activity
and faster 4-meter walking velocity (Table).
Analyses in Fig 1 and Fig 2 and the Table that included
Caltrac vertical accelerometer data were repeated, with
additional adjustment for missing data using inverse
weighting. Results were similar to those presented in Fig 1
and 2 and the Table (data not shown). Analyses for Fig 1
and 2 and the Table were repeated, in which the ABI
covariate was calculated using the highest pressure in each
leg for the analysis. Results were similar to those presented
in Fig 1 and Fig 2 and the Table.
DISCUSSION
Previous studies suggest that lower extremity ischemia
has a direct, negative effect on calf muscle area.1-4 In
addition, lower calf muscle area among individuals with
PAD is associated with poorer 6-minute walk performance
and slower walking speed.4 Clinical characteristics associ-
ated with lower calf muscle area in people with PAD are
largely unknown, however. Results reported here show that
higher physical activity levels during daily life, measured
both objectively and by patient report, are associated with
higher calf muscle area and higher calf muscle density in
participants with PAD. In contrast, these results suggest
that no significant associations exist between walking exer-
cise frequency and calf muscle characteristics in PAD par-
ticpants and that patient-reported walking exercise may
neither benefit nor harm calf muscle characteristics in per-
sons with PAD.
The differences observed in associations of walking
exercise vs physical activity with calf muscle characteristics
have several potential explanations. Walking activity during
exercise may be more intensive than casual walking associ-
ated with activity during daily life. Patients with PAD may
walk to maximal leg pain during walking exercise, but may
walk only to the onset of exertional leg pain during daily
physical activities. Because intensive walking tomaximal leg
pain during exercise is expected to induce greater leg
ischemia than more casual walking during daily activities,
and greater lower extremity ischemia is associated with
adverse calf muscle characteristics,4 more intensive walking
exercise may be associated with less favorable calf muscle
characteristics compared with less intensive walking activ-
ity.
Alternatively, the patient-reported measure of walk-
ing exercise frequency may be a less valid measure than
accelerometer-measured physical activity or the patient-
reported physical activity measure of the number of
blocks walked during the past week. It is not intuitively
clear, however, why the patient-reported measure of
number of blocks walked during the prior week would be
a more valid measure than patient-reported walking ex-
ercise frequency. In addition, the patient-reported walk-
ing exercise question used has been previously demon-
strated to be associated significantly with average annual
decline in functional performance among individuals
with PAD.5
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patients with PAD and suggest that increasing physical
activity during daily life may have beneficial consequences
for calf muscle in patients with PAD. These findings sug-
gest that physicians should urge their patients with PAD to
increase their walking physical activity, even if their patient
does not engage in walking exercise behavior. Our results
also suggest that more study is needed to determine
whether less intensive walking exercise (ie, walking to the
onset of exertional leg symptoms) may be more beneficial
to calf skeletal muscle than more intensive walking exercise
(ie walking to maximal leg symptoms) in patients with
PAD.
Findings reported here also suggest that more favorable
calf muscle characteristics in study participants with PAD
who are more physically active may partly explain the
observed associations between higher physical activity lev-
els and faster 4-meter walking velocity. In this case, in-
creased physical activity may increase calf muscle area,
which in turn may contribute to faster walking speed over
short distances. However, significant associations between
higher objectively measured physical activity and better
6-minute walk performance did not appear to be explained
by more favorable calf muscle characteristics among more
physically active study participants. The associations be-
tween higher physical activity levels and better 6-minute
walk performance remained highly statistically significant
even after taking into account calf muscle characteristics in
statistical analyses.
These results suggest that factors other than muscle
area or density may explain the observed associations be-
tween higher objectively measured physical activity levels
and better 6-minute walk performance. Potential alterna-
tive explanations for this observed association include more
efficient muscle metabolism, improved cardiovascular fit-
ness, or more efficient gait characteristics in more physically
active PAD patients. Because the 6-minute walk is a mea-
sure of walking endurance, whereas the 4-meter walk mea-
sures speed over a short distance, mechanisms of better
performance may differ between each of these two func-
tional performance assessments.
Previous study by Hiatt et al27 demonstrated that
treadmill walking exercise was associated with a higher
percentage of denervated muscle fibers and increased mus-
cle connective tissue content among 26 patients with inter-
mittent claudication who were randomized to 12 weeks of
treadmill exercise, strength training, or a control group.
Treadmill exercise was not associated with changes in type
I or type II fiber area in the leg with most severe PAD;
however, type II fiber area significantly decreased in the leg
with less severe PAD. No changes in muscle fiber denerva-
tion, number, or connective tissue content were observed
in the strength-trained or control groups.27 To our knowl-
edge, no prior studies have assessed associations between
walking exercise frequency or physical activity levels and
CT-measured calf muscle characteristics in a large cohort of
participants with PAD.This study has limitations. First, data are cross-
sectional. Associations reported here between greater phys-
ical activity levels and more favorable calf muscle character-
istics may not be causal.
Second, we did not collect data on intensity of walking
activity or exercise. It is conceivable that differences in
associations between physical activity and walking exercise
with calf muscle characteristics may be due to differences in
walking intensity between walking activity during daily life
and walking during exercise.
Third, because 60% of PAD participants wore the Cal-
trac vertical accelerometer, we cannot be certain that our
findings are generalizable to the PAD participants who did
not wear the Caltrac accelerometer. However, analyses
performed using the technique of inverse weighting to
adjust for missing data suggest that our results for the
Caltrac vertical accelerometer are likely to be similar to
results for the entire cohort.
Fourth, our study design does not allow us to deter-
mine reasons for the discrepancy in findings between the
physical activity and patient-reported walking exercise mea-
sures.
Finally, this study focuses on associations between
walking activity and calf muscle characteristics. Associations
between other forms of activity and calf muscle character-
istics were not evaluated.
CONCLUSION
PAD patients with higher physical activity levels during
daily life have more favorable calf skeletal muscle character-
istics than PAD patients with lower activity. More favorable
calf muscle characteristics in more physically activity per-
sons with PAD may explain some of the observed associa-
tions between greater physical activity levels and better
lower extremity performance in individuals with PAD. In
contrast, participants with PADwho reported regular walk-
ing exercise had neither more or less favorable calf muscle
characteristics. Nonetheless, it is important to note that
multiple prior clinical trials demonstrate significant im-
provement in walking endurance in response to supervised
treadmill walking exercise in persons with PAD.28 Our data
also suggest that physicians should encourage patients with
PAD to increase their walking activity during daily life.
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